New MRD Assessment Data Using clonoSEQ® To Be Presented at 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Read More

EHA2024 Hybrid Congress

The EHA2024 Hybrid Congress scientific program will focus on cutting-edge hematology and various topics, including hemostasis and thrombosis, hematologic malignancies, transfusion medicine, and stem cell transplantation.